This is a synthetic peptide designed for use in combination with anti-DBNL antibody (Catalog #: ARP54437_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
DBNL
Reaktivität: Human, Maus
Wirt: Synthetic
BP, BI
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
DBNL
(Drebrin-Like (DBNL))
Hintergrund
DBNL is an actin-binding adapter protein. DBNL may act as a common effector of antigen receptor-signaling pathways in leukocytes. Its association with dynamin suggests that it may also connect the actin cytoskeleton to endocytic function. DBNL acts as a k
Alias Symbols: ABP1, HIP-55, SH3P7
Protein Interaction Partner: DBNL,MAP4K1,NEURL4,SH2D4A,SH3BP2,SYK,ZAP70,CASP3,CDK4,CYP4F8,DNPEP,EIF2AK2,GPS2,HERC2,MAP4K1,RB1CC1,SH2D4A,ZAP70